/

Rhino Biotech Limited

RBRXF US

RBRXF USRhino Biotech Limited

United States Composite

10.00

USD

- -

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

Rhino Biotech Limited

RBRXF:US

(United States Composite)

Recent

price

10.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

Legends:

Stock price

- -

Beta (1.0 Market)

% total return 12/10

Stock

S&P500

YTD

- -

666,566.65

- -

769,130.75

- -

FRC

- -

Capital Structure

FRC

•

in mil. unless spec.

ST Debt

LT Borrowings

LT Finance Leases

Preferred Equity and Hybrid Capital

Shares Outstanding

Market Capitalization

Working Capital

FRC

•

in mil. unless spec.

Total Current Assets

Cash, Cash Equivalents & STI

Accounts Receivable, Net

Inventories

Total Current Liabilities

Payables & Accruals

ST Debt

Deferred Revenue

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

- -

Net Income, GAAP

- -

Free Cash Flow

- -

Total Cash Common Dividend

- -

Total Equity

- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

-Infinity

- -

-Infinity

- -

-Infinity

- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

-Infinity

- -

-Infinity

- -

-Infinity

- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

-Infinity

- -

-Infinity

- -

-Infinity

- -

Business: Rhino Biotech Limited intends to develop plant and fungi derived nutraceuticals, and preventative and curative biopharmaceuticals. The company was formerly known as Eurasia Energy Limited and changed its name to Rhino Biotech Limited in September 2021. Rhino Biotech Limited was incorporated in 2003 and is based in South Hill, Anguilla.

- -

FRC

- -